Primary Site >> Liver Cancer

Gene >> NHS

  • 2000
  • 2005
  • 2006
  • 2008
  • 2009
  • 2012
  • 2013
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Spontaneously occurring hepatocellular neoplasia in adolescent cynomolgus monkeys (Macaca fascicularis).
PMID: 11105957
Ref: Hepatitis C: tackling the silent epidemic.
PMID: 16255265
Ref: Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
PMID: 16904047
Ref: The cost-effectiveness of testing for hepatitis C in former injecting drug users.
PMID: 16948891
Ref: Surveillance of cirrhosis for hepatocellular carcinoma: a cost-utility analysis.
PMID: 18382459
Ref: NICE rules that drug used in advanced liver cancer is not cost effective for the NHS.
PMID: 19933742
Ref: Autoantibodies against glucose-regulated protein 78 as serological diagnostic biomarkers in hepatocellular carcinoma.
PMID: 22692946
Ref: Hepatitis C infection and outcomes in the Scottish haemophilia population.
PMID: 23786361
Ref: Preparation, characterization, and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles.
PMID: 24471890
Ref: Preparation of magnetic resonance probes using one-pot method for detection of hepatocellular carcinoma.
PMID: 25892879
Ref: Liver-allocation policies for patients affected by HCC in Europe.
PMID: 28473952
Ref: Liver cancer drug is rejected for routine NHS use but will remain in Cancer Drugs Fund.
PMID: 28049164
Ref: The European Policy for Liver Allocation in Patients Affected by Hepatocellular Carcinoma.
PMID: 28675357
Ref: The Royal Free Hospital 'hub-and-spoke network model' delivers effective care and increased access to liver transplantation.
PMID: 29248826
Ref: Conjugation of phthalocyanine photosensitizer with poly(amidoamine) dendrimer: improved solubility, disaggregation and photoactivity against HepG2 cells.
PMID: 29984658
Ref: Cancer-testis antigen GAGE-1 expression and serum immunoreactivity in hepatocellular carcinoma.
PMID: 30297572